Deep Brain Photonic Tools for Cell-Type Specific Targeting of Neural Diseases
OptogeniX is partner in an international consortium created to exploit photonics for revealing the molecular and cellular dysfunctions underlying the pathogenesis of neurological diseases. The goal is to create a technology able to lead to less invasive and more effective treatments of dramatic social impacting pathologies, such as Alzheimer’s disease, depression, schizophrenia. The DEEPER project is funded by the European Union through the Research and Innovation Action (RIA) on Disruptive photonics technologies, with approx 7 million euros funded for 2021-2025. For more information: https://deeperproject.eu/.